Active Coping Program for Chronic Musculoskeletal Pain: A Controlled Clinical Study
Effectiveness of an Active Coping Program on Pain, Disability, and Psychosocial Factors in Patients With Chronic Musculoskeletal Pain: A Controlled Clinical Study
1 other identifier
interventional
169
1 country
1
Brief Summary
Chronic musculoskeletal pain is a highly prevalent condition that is often associated with persistent pain, physical disability, and maladaptive psychosocial factors such as pain catastrophizing, fear of movement, and central sensitization. These factors can contribute to pain persistence and reduced quality of life, highlighting the need for multimodal, non-pharmacological interventions that address both physical and psychological dimensions of pain. The purpose of this study is to evaluate the effectiveness of an active coping program for patients with chronic musculoskeletal pain compared with usual care. The intervention is designed to promote active pain management strategies through education, movement-based exercises, and behavioral approaches aimed at improving pain coping, reducing disability, and addressing psychosocial contributors to chronic pain. This is a controlled interventional study in which adult patients with chronic musculoskeletal pain will be allocated to either an intervention group receiving the active coping program or a control group receiving usual care. Outcome measures will be assessed at baseline and after completion of the intervention. Primary and secondary outcomes include pain-related disability, pain catastrophizing, fear of movement, symptoms of central sensitization, and health-related quality of life, measured using validated questionnaires. The findings of this study are expected to provide evidence on the clinical effectiveness of an active coping approach in the management of chronic musculoskeletal pain and to support its implementation in routine clinical practice within primary care settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedApril 29, 2026
April 1, 2026
2 months
December 16, 2025
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Pain Catastrophizing Scale (PCS)
The Pain Catastrophizing Scale (PCS) is a self-reported questionnaire assessing catastrophic thinking related to pain, including rumination, magnification, and helplessness. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing (worse outcome).
Baseline (Week 0) and post-intervention (Week 8)
Roland-Morris Disability Questionnaire (RMDQ)
The Roland-Morris Disability Questionnaire (RMDQ) is a self-reported questionnaire assessing pain-related physical disability in daily activities. The total score ranges from 0 to 24, with higher scores indicating greater disability (worse outcome).
Baseline (Week 0) and post-intervention (Week 8)
Tampa Scale for Kinesiophobia (TSK-11)
The Tampa Scale for Kinesiophobia - 11 item version (TSK-11) is a self-reported questionnaire assessing fear of movement and re-injury related to pain. Total scores range from 11 to 44, with higher scores indicating greater kinesiophobia (worse outcome).
Baseline (Week 0) and post-intervention (Week 8)
Central Sensitization Inventory (CSI)
The Central Sensitization Inventory (CSI) is a self-reported questionnaire used to assess symptoms associated with central sensitization. The total score ranges from 0 to 100, with higher scores indicating greater symptom severity related to central sensitization (worse outcome).
Baseline (Week 0) and post-intervention (Week 8)
36-Item Short Form Health Survey (SF-36)
The 36-Item Short Form Health Survey (SF-36) is a generic self-reported questionnaire assessing health-related quality of life across multiple physical and mental health domains. Each domain score ranges from 0 to 100, with higher scores indicating better health-related quality of life (better outcome).
Baseline (Week 0) and post-intervention (Week 8)
Study Arms (2)
Active Coping Program
EXPERIMENTALUsual Care
ACTIVE COMPARATORInterventions
Participants assigned to this arm will receive usual care as provided in routine clinical practice in primary care. No additional study-specific intervention is delivered. Usual care may include standard medical management, general advice and education, and referral to other services as clinically indicated, according to local practice.
Participants assigned to this arm will receive an 8-week active coping program for chronic musculoskeletal pain. The program is a multimodal, non-pharmacological intervention aimed at improving self-management and active pain coping. Core components include pain education (e.g., understanding chronic pain mechanisms), movement-based therapeutic exercise/graded activity, and behavioral strategies to address maladaptive pain-related beliefs and behaviors (e.g., fear of movement and pain catastrophizing). The intervention is delivered following a standardized protocol to ensure consistency across participants.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older.
- Diagnosis of chronic musculoskeletal pain, defined as pain persisting for more than 3 months.
- Ability to understand study procedures and complete self-reported questionnaires.
- Ability to participate in an active coping program involving education and movement-based activities.
- Provision of written informed consent.
You may not qualify if:
- Presence of serious neurological, rheumatologic, or systemic disease that may interfere with participation in the intervention or outcome assessment.
- Severe cognitive impairment or psychiatric condition that limits understanding of the study procedures.
- Ongoing participation in another structured pain management or rehabilitation program.
- Any medical condition that, in the opinion of the investigators, would make participation unsafe or compromise study results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Extremadura
Badajoz, Badajoz, 06006, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Luis Espejo-Antúnez, Ph.D.
University of Extremadura
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 16, 2025
First Posted
January 7, 2026
Study Start
February 1, 2026
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share